scholarly journals Healthy eating index/alternative healthy eating index and breast cancer mortality and survival: A systematic review and meta-analysis

2016 ◽  
Vol 3 (3) ◽  
pp. 297 ◽  
Author(s):  
Maryam Miraghajani ◽  
Makan Pourmasoumi ◽  
Razieh Karimbeiki ◽  
Nooshin Vosoughi ◽  
Awat Feizi ◽  
...  
2017 ◽  
Vol 118 (3) ◽  
pp. 210-221 ◽  
Author(s):  
Nitin Shivappa ◽  
James R. Hebert ◽  
Mika Kivimaki ◽  
Tasnime Akbaraly

AbstractWe aimed to examine the association between the Alternative Healthy Eating Index updated in 2010 (AHEI-2010), the Dietary Inflammatory Index (DIITM) and risk of mortality in the Whitehall II study. We also conducted a meta-analysis on the DII-based results from previous studies to summarise the overall evidence. Data on dietary behaviour assessed by self-administered repeated FFQ and on mortality status were available for 7627 participants from the Whitehall II cohort. Cox proportional hazards regression models were performed to assess the association between cumulative average of AHEI-2010 and DII scores and mortality risk. During 22 years of follow-up, 1001 participants died (450 from cancer, 264 from CVD). Both AHEI-2010 (mean=48·7 (sd10·0)) and DII (mean=0·37 (sd1·41)) were associated with all-cause mortality. The fully adjusted hazard ratio (HR) persd, were 0·82; 95 % CI 0·76, 0·88 for AHEI-2010 and 1·18; 95 % CI 1·08, 1·29 for DII. Significant associations were also observed with cardiovascular and cancer mortality risk. For DII, a meta-analysis (using fixed effects) from this and four previous studies showed a positive association of DII score with all-cause (HR=1·04; 95 % CI 1·03, 1·05, 28 891deaths), cardiovascular (HR=1·05; 95 % CI 1·03, 1·07, 10 424 deaths) and cancer mortality (HR=1·05; 95 % CI 1·03, 1·07,n8269).The present study confirms the validity to assess overall diet through AHEI-2010 and DII in the Whitehall II cohort and highlights the importance of considering diet indices related to inflammation when evaluating all-cause, cardiovascular and cancer mortality risk.


2015 ◽  
Vol 57 (10) ◽  
pp. 1999-2008 ◽  
Author(s):  
Sarah F. Brennan ◽  
Jayne V. Woodside ◽  
Paula M. Lunny ◽  
Chris R. Cardwell ◽  
Marie M. Cantwell

Cancers ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 976
Author(s):  
Amanda Dibden ◽  
Judith Offman ◽  
Stephen W. Duffy ◽  
Rhian Gabe

In 2012, the Euroscreen project published a review of incidence-based mortality evaluations of breast cancer screening programmes. In this paper, we update this review to October 2019 and expand its scope from Europe to worldwide. We carried out a systematic review of incidence-based mortality studies of breast cancer screening programmes, and a meta-analysis of the estimated effects of both invitation to screening and attendance at screening, with adjustment for self-selection bias, on incidence-based mortality from breast cancer. We found 27 valid studies. The results of the meta-analysis showed a significant 22% reduction in breast cancer mortality with invitation to screening, with a relative risk of 0.78 (95% CI 0.75–0.82), and a significant 33% reduction with actual attendance at screening (RR 0.67, 95% CI 0.61–0.75). Breast cancer screening in the routine healthcare setting continues to confer a substantial reduction in mortality from breast cancer.


Trials ◽  
2013 ◽  
Vol 14 (1) ◽  
pp. 368 ◽  
Author(s):  
Sylvie Erpeldinger ◽  
Laure Fayolle ◽  
Rémy Boussageon ◽  
Marie Flori ◽  
Xavier Lainé ◽  
...  

2014 ◽  
Vol 8 (3) ◽  
pp. 402-409 ◽  
Author(s):  
Catherine Marinac ◽  
Ruth E. Patterson ◽  
Adriana Villasenor ◽  
Shirley W. Flatt ◽  
John P. Pierce

Sign in / Sign up

Export Citation Format

Share Document